Affiliation:
1. Krasnoyarsk State Medical University
2. Krasnoyarsk State Medical University;
Krasnoyarsk Regional Clinical Hospital
3. Krasnoyarsk Regional Clinical Hospital
Abstract
Objective: to evaluate the early and long-term outcomes of cadaveric kidney allotransplantation (CKAT) based on a retrospective analysis of 71 cases treated at Krasnoyarsk Regional Clinical Hospital (KRCH).Materials and methods. From March 2014 to June 2019, 71 kidney transplants were performed at KRCH – 42 (59.15%) men and 29 (40.85%) women. The age of the patients varied from 20 to 59 years (mean age 39.6 ± 8.14 years). The causes of end-stage chronic kidney disease which subsequently led to CKAT were chronic glomerulonephritis, chronic tubulointerstitial nephritis, hypertensive nephropathy (HN), diabetic nephropathy resulting from type I diabetes (DN), nephropathy of mixed genesis (HN + DN), vesicoureteral reflux, congenital angiodysplasia of the kidneys, and Alport syndrome. The mean number of HLA mismatches was 4.5 ± 0.9.Results. Hospitalization lasted for an average of 34.05 ± 9.56 days. Primary function was observed in 32 (45.08%) patients, while 39 (54.92%) cases had delayed function. Post-transplant complications were noted in 23 (32.39%) patients, of whom 12 (16.9%) had early post-transplant complications, while 15 (21.13%) encountered complications in the late post-transplant period. The most frequently diagnosed were immunological, infectious, and urological complications. Vascular, surgical, oncological, and other complications were less frequent. The annual graft survival rate was 87.3%. Patient survival rate was 95.77%. One (1.4%) and 2 (2.81%) patients died in the early and late post-transplant periods, respectively. Hospital mortality – 1 case (1.4%).Conclusion. Kidney transplantation is the most effective treatment for patients with irreversible chronic kidney disease. About 87.33% of transplants were found to be effective. However, 32.39% of patients had postoperative complications. The vast majority of complications were reversible and were corrected conservatively or surgically. Nevertheless, graft loss occurred in 12.67% of cases. The success of transplantation depends on a number of factors related to both the donor and the recipient, as well as the immunological status and surgical technique. A personalized approach to recipients helps to reduce postoperative complications, prevent nephrotoxicity and rejection reactions.
Publisher
V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs
Subject
Transplantation,Immunology and Allergy
Reference18 articles.
1. Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011 Mar; 11 (3): 450–462. doi: 10.1111/j.1600-6143.2010.03283.x. Epub 2010 Oct 25. PMID: 20973913.
2. Tomilina NA, Andrusev AM, Peregudova NG, Shinkarev MB. Renal replacement therapy for End Stage Renal Disease in Russian Federation, 2010–2015. Russian National Renal Replacement Therapy Registry Report of Russian Public Organization of Nephrologists «Russian Dialysis Society», Part 1. Nefrologiya i dializ [Nephrology and dialysis]. 2017; 19 (4, supplement): 1–95. doi: 10.28996/1680-4422-2017-4sup-pl-1-95. [In Russ, English abstract].
3. Kramer A, Boenink R, Noordzij M, Bosdriesz JR, Stel VS, Beltrán P et al. The ERA-EDTA Registry Annual Report 2017: a summary. Clin Kidney J. 2020 Jun 22; 13 (4): 693–709. doi: 10.1093/ckj/sfaa048. PMID: 32897277; PMCID: PMC7467580.
4. Smirnov AV, Dobronravov VA, Kayukov IG, BodurOorzhak AS, Essaian AM, Kucher AG. Epidemiology and social-economical aspects of chronic kidney disease. Nephrology. 2006; 10 (1): 7–13. https://doi.org/10.24884/1561-6274-2006-10-1-7-13 [In Russ].
5. Gautier SV, Khomyakov SM. Organ donation and transplantation in the Russian Federation in 2018. 11th report of the Registry of the Russian Transplant Society. Russian Journal of Transplantology and Artificial Organs. 2019; 21 (3): 7–32. https://doi.org/10.15825/1995-1191-2019-3-7-32.